- Investing Ideas
- /
- Pakistani Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Pakistani Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
4
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
4 companies
GlaxoSmithKline Pakistan
Market Cap: PK₨131.3b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨412.36
7D
1.5%
1Y
139.6%
Highnoon Laboratories
Market Cap: PK₨60.8b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨1,147.45
7D
-1.3%
1Y
66.7%
Hoechst Pakistan
Market Cap: PK₨38.6b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨3,998.00
7D
-2.3%
1Y
92.2%
Abbott Laboratories (Pakistan)
Market Cap: PK₨114.4b
Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.
ABOT
PK₨1,168.20
7D
-0.8%
1Y
52.7%